Khanmammadov, N. Et Al. 2024. Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer. Medicine (United States) , vol.103, no.1 .

Khanmammadov, N., Doǧan, I., Okay, N. S., AZİZY, A., Saip, P., & AYDINER, A., (2024). Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer. Medicine (United States) , vol.103, no.1.

Khanmammadov, Nıjat Et Al. "Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer," Medicine (United States) , vol.103, no.1, 2024

Khanmammadov, Nıjat Et Al. "Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer." Medicine (United States) , vol.103, no.1, 2024

Khanmammadov, N. Et Al. (2024) . "Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer." Medicine (United States) , vol.103, no.1.

@article{article, author={Nıjat KHANMAMMADOV Et Al. }, title={Comparative analysis of doublet chemotherapy regimens plus bevacizumab in patients with recurrent ovarian cancer}, journal={Medicine (United States)}, year=2024}